JP2012502061A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502061A5 JP2012502061A5 JP2011526247A JP2011526247A JP2012502061A5 JP 2012502061 A5 JP2012502061 A5 JP 2012502061A5 JP 2011526247 A JP2011526247 A JP 2011526247A JP 2011526247 A JP2011526247 A JP 2011526247A JP 2012502061 A5 JP2012502061 A5 JP 2012502061A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- composition
- composition according
- hours
- zein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 239000004480 active ingredient Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 11
- 229920002494 Zein Polymers 0.000 claims 8
- 239000008188 pellet Substances 0.000 claims 8
- 239000005019 zein Substances 0.000 claims 8
- 229940093612 zein Drugs 0.000 claims 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 6
- 229920000881 Modified starch Polymers 0.000 claims 6
- 239000000463 material Substances 0.000 claims 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 6
- 238000013268 sustained release Methods 0.000 claims 6
- 239000012730 sustained-release form Substances 0.000 claims 6
- 239000008187 granular material Substances 0.000 claims 5
- 238000002156 mixing Methods 0.000 claims 5
- 239000006185 dispersion Substances 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 3
- 239000008199 coating composition Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 claims 2
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- DYWNLSQWJMTVGJ-KUSKTZOESA-N Phenylpropanolamine hydrochloride Chemical compound Cl.C[C@H](N)[C@H](O)C1=CC=CC=C1 DYWNLSQWJMTVGJ-KUSKTZOESA-N 0.000 claims 2
- 235000013869 carnauba wax Nutrition 0.000 claims 2
- 239000004203 carnauba wax Substances 0.000 claims 2
- 238000004090 dissolution Methods 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000010828 elution Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 2
- 229940060367 inert ingredients Drugs 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002844 melting Methods 0.000 claims 2
- 230000008018 melting Effects 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 229960002305 phenylpropanolamine hydrochloride Drugs 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 229960004380 tramadol Drugs 0.000 claims 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 208000017667 Chronic Disease Diseases 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000004513 sizing Methods 0.000 claims 1
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9436308P | 2008-09-04 | 2008-09-04 | |
| US61/094,363 | 2008-09-04 | ||
| PCT/US2009/056103 WO2010028290A1 (en) | 2008-09-04 | 2009-09-04 | Chewable sustained release formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502061A JP2012502061A (ja) | 2012-01-26 |
| JP2012502061A5 true JP2012502061A5 (cg-RX-API-DMAC7.html) | 2012-09-20 |
| JP5608653B2 JP5608653B2 (ja) | 2014-10-15 |
Family
ID=41219093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526247A Expired - Fee Related JP5608653B2 (ja) | 2008-09-04 | 2009-09-04 | チュアブルな徐放性製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10668012B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2331076B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5608653B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102202654B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009289464B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2736119C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2536736T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010028290A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1400578B1 (it) | 2010-06-18 | 2013-06-14 | Alpex Pharma Sa | Processo per la preparazione di compresse a rilascio controllato. |
| US10722458B2 (en) * | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
| WO2013082470A1 (en) | 2011-12-02 | 2013-06-06 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
| CA2871821C (en) | 2012-05-10 | 2021-01-12 | Painreform Ltd. | Depot formulations of a local anesthetic and methods for preparation thereof |
| CN103686676A (zh) * | 2012-08-31 | 2014-03-26 | 中兴通讯股份有限公司 | 设备到设备通信系统的通信方法、装置及系统 |
| US20140080908A1 (en) * | 2012-09-19 | 2014-03-20 | Phyto Tech Corp. | Compositions and methods for improving or preventing depression-like symptoms |
| JP6378702B2 (ja) | 2013-03-15 | 2018-08-22 | アルジェンタ マニュファクチャリング リミティド | チュアブル製剤 |
| JP7418958B2 (ja) | 2016-03-17 | 2024-01-22 | チオジェネシス セラピューティクス， インコーポレイテッド | システアミンの制御放出のための組成物及びシステアミン感受性障害の全身治療 |
| JP6800596B2 (ja) * | 2016-03-29 | 2020-12-16 | 小林製薬株式会社 | 錠剤 |
| EP3519812A4 (en) | 2016-09-27 | 2020-06-17 | Zolentroff, William C. | ALA AND SALT FORMULATION |
| WO2019021191A1 (en) * | 2017-07-26 | 2019-01-31 | Tgx Soft Chew, Llc | STARCH-FREE MOUTH PRODUCT FOR VETERINARY APPLICATIONS |
| CN109420163B (zh) * | 2017-08-23 | 2022-06-21 | 中山市力恩普制药有限公司 | 治疗呼吸道感染的药物组合物及其制备方法和用途 |
| EP4534527A3 (en) | 2017-09-20 | 2025-06-18 | Thiogenesis Therapeutics, Inc. | Methods for the treatment of cysteamine sensitive disorders |
| EP3902523A1 (en) * | 2018-12-29 | 2021-11-03 | 3M Innovative Properties Company | Oral articles and methods of use |
| WO2020136604A2 (en) * | 2018-12-29 | 2020-07-02 | 3M Innovative Properties Company | Oral articles and methods of use |
| CN111744018A (zh) * | 2019-03-26 | 2020-10-09 | 北京福元医药股份有限公司 | 一种盐酸氨基葡萄糖药物制剂 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3567819A (en) * | 1969-01-30 | 1971-03-02 | Hoffmann La Roche | Cold tablet |
| US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
| GB8913889D0 (en) | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
| US5182130A (en) * | 1989-11-06 | 1993-01-26 | Opta Food Ingredients, Inc. | Method for producing an edible prolamine coating from an aqueous latex |
| US5077053A (en) * | 1990-02-12 | 1991-12-31 | Warner-Lambert Company | Zein as a moisture barrier for sugarless edible compositions and method for preparing same |
| US5599556A (en) * | 1991-12-31 | 1997-02-04 | Abbott Laboratories | Prolamine coatings for taste masking |
| US6210714B1 (en) * | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| DE19630035A1 (de) | 1996-07-25 | 1998-01-29 | Asta Medica Ag | Tramadol Multiple Unit Formulierungen |
| JP3877083B2 (ja) * | 1996-08-03 | 2007-02-07 | 昭和産業株式会社 | 第４胃以降消化・吸収性反芻動物用飼料製剤並びにそれを含有する反芻動物用飼料 |
| FR2752732B1 (fr) | 1996-08-28 | 1998-11-20 | Pf Medicament | Forme galenique a liberation prolongee de milnacipran |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| CA2322641C (en) * | 1998-03-23 | 2010-02-16 | General Mills, Inc. | Encapsulation of components into edible products |
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| EP1623703B1 (en) * | 1999-10-29 | 2011-10-05 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
| US6277409B1 (en) * | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
| US20020106408A1 (en) * | 2000-12-01 | 2002-08-08 | Johnatan Bacon | Prolamin-based sustained-release compositions and delayed-onset compositions |
| EP1248599B1 (de) | 2001-01-31 | 2007-12-05 | Evonik Röhm GmbH | Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen |
| US20030228368A1 (en) * | 2001-09-28 | 2003-12-11 | David Wynn | Edible solid composition and dosage form |
| US7612112B2 (en) * | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
| KR20050047507A (ko) | 2002-06-27 | 2005-05-20 | 시락 아게 | 구형 펠렛 제제 |
| AU2003247876B2 (en) * | 2002-07-05 | 2006-10-05 | Collegium Pharmaceutical, Inc | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| GB2403407B (en) * | 2003-07-03 | 2006-12-13 | Michael Hilary Burke | Palatable oral anthelmintic composition |
| EP1689367A1 (en) * | 2003-10-21 | 2006-08-16 | Actavis Group HF | Pharmaceutical formulations containing quetiapine |
| US20050089558A1 (en) | 2003-10-28 | 2005-04-28 | Alamo Pharmaceuticals, Llc | Compositions and methods for the co-formulation and administration of tramadol and propoxyphene |
| NZ555501A (en) * | 2004-11-24 | 2010-01-29 | Medpointe Healthcare Inc | Compositions comprising azelastine and methods of use thereof |
| WO2006082824A1 (ja) | 2005-02-03 | 2006-08-10 | Nrl Pharma, Inc. | マトリックス型腸溶性・徐放性組成物 |
| JP4602949B2 (ja) | 2006-08-02 | 2010-12-22 | 和光堂株式会社 | 被覆粒子含有組成物及びその製造方法 |
-
2009
- 2009-09-04 AU AU2009289464A patent/AU2009289464B2/en not_active Ceased
- 2009-09-04 WO PCT/US2009/056103 patent/WO2010028290A1/en not_active Ceased
- 2009-09-04 EP EP09792287.6A patent/EP2331076B1/en not_active Not-in-force
- 2009-09-04 CA CA2736119A patent/CA2736119C/en active Active
- 2009-09-04 US US12/554,361 patent/US10668012B2/en active Active
- 2009-09-04 JP JP2011526247A patent/JP5608653B2/ja not_active Expired - Fee Related
- 2009-09-04 CN CN200980143789.3A patent/CN102202654B/zh not_active Expired - Fee Related
- 2009-09-04 ES ES09792287.6T patent/ES2536736T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502061A5 (cg-RX-API-DMAC7.html) | ||
| US20210113469A1 (en) | Sustained release compositions using wax-like materials | |
| CN102202654B (zh) | 可咀嚼的缓释制剂 | |
| KR101476574B1 (ko) | 서방성 하이드로코돈 제형 | |
| EP0785775B2 (en) | Melt-extruded orally administrable opioid formulations | |
| CN1942174B (zh) | 微粒 | |
| JP2017031206A (ja) | ラコサミドの１日１回投与用製剤 | |
| TW200427448A (en) | Controlled release preparations comprising tramadol and topiramate | |
| CN103520130B (zh) | 孟鲁斯特钠择时控释片及其制备方法 | |
| CN103520136B (zh) | 孟鲁斯特钠脉冲胶囊及其制备方法 | |
| KR20090047310A (ko) | 덱시부프로펜을 함유하는 다층정제 | |
| CN103222968A (zh) | 一种含有氟尼辛葡甲胺的片剂及其制备方法 | |
| CN101537005B (zh) | 可待因和氯苯那敏复方缓释胶囊 | |
| CN116350596A (zh) | 利培酮速释缓释双释放制剂及其制备方法 | |
| HK1141441B (en) | Sustained release pellets comprising wax-like material | |
| JP2006089461A (ja) | 覚醒剤原料含有レイアリング顆粒 | |
| HK1069110B (en) | Melt-extruded orally administrable opioid formulations |